Portal de investigação
Influence of Cystic Fibrosis-Related Diabetes on the Severity of Cystic Fibrosis Phenotype
Dados básicos
- Código:
- Estudo Clínico Académico
- Protocolo:
- Estudo Clínico Académico
- EUDRACT:
- NCT:
- Centro:
- Dotação:
- Ano de início:
- 2022
- Ano de conclusão:
Objectivos do projeto
Estudos Observacionais (STROBE statement); Natureza do Promotor: Academia – Tipo não comercial – Iniciativa do Investigador; Tipo de Centro: Unicêntrico – Cuidados Secundários
Documentos
- Não há documentos
Participantes
Unidades de investigação
Stakeholders - Promotores
Outputs do ensaio clínico
2023 UPDATE: Luso-Brazilian evidence-based guideline for the management of antidiabetic therapy in type 2 diabetes
Bertoluci, MC; (...); Carvalho, D.
Review. 10.1186/s13098-023-01121-x. 2023
2023 UPDATE: Luso-Brazilian evidence-based guideline for the management of antidiabetic therapy in type 2 diabetes.
Bertoluci, MC; (...); Carvalho, D
Review. 2023
A 4-variable model to predict cardio-kidney events and mortality in chronic kidney disease: The Chronic Renal Insufficiency Cohort (CRIC) Study
Mendon?a, L.; (...); Ferreira, J.
Article. 10.1159/000533223. 2023
A 4-variable model to predict cardio-kidney events and mortality in chronic kidney disease: The Chronic Renal Insufficiency Cohort (CRIC) Study.
Mendonça, LCF; (...); Ferreira, JP
Article. 2023
Adherence to glucose monitoring with intermittently scanned continuous glucose monitoring in patients with type 1 diabetes
Sousa, C; (...); Sampaio, R
Article. 10.1007/s12020-022-03288-1. 2023
Adherence to glucose monitoring with intermittently scanned continuous glucose monitoring in patients with type 1 diabetes.
Sousa, C; (...); Sampaio, R
Article. 2023
Albiglutide in patients with type 2 diabetes and heart failure: a post-hoc analysis from Harmony Outcomes
Ferreira, J.; (...); Neves, J.
Article. 10.1002/ejhf.2660. 2022
Association of combined fractional excretion of phosphate and FGF23 with heart failure and cardiovascular events in moderate and advanced renal disease.
Mendonça, L, Vieira, MB, Neves, JS
Article. 2023
Association of glycemic variability and time in range with lipid profile in type 1 diabetes
Salsa-Castelo, Mariana; (...); Carvalho, Davide
Article. 10.1007/s12020-023-03464-x. 2024
Association of metabolic syndrome components and NAFLD with quality of life: Insights from a cross-sectional study.
Borges-Canha, M; (...); Neves, JS
Article. 2024
Association of thyroid function, within the euthyroid range, with cardiovascular risk: The EPIPorto study
Neves, J.; (...); Azevedo, A.
Article. 10.3389/fendo.2022.1067801. 2022
Breastfeeding Associated with Lower Prevalence of Metabolic Syndrome in Women with Gestational Diabetes in the Very Early Postpartum Period.
Blair, RA; (...); Seely, EW
Article. 2024
Cardiovascular Prevention in Obese Patients Without Diabetes: Risk-based Strategies Are Needed
Ferreir, Joao Pedro, Neves, Joao Sergio, Saraiva, Francisca
Editorial Material. 10.1016/j.cardfail.2023.12.002. 2024
Cardiovascular Prevention in Obese Patients Without Diabetes: Risk-based Strategies Are Needed.
Ferreira, JP, Neves, JS, Saraiva, F
Article. 2024
Clinical and Pathophysiologic Insights of Free triiodothyronine/Free thyroxine Ratio in Patients with Heart Failure with Preserved Ejection Fraction: Data from the NETDiamond Cohort
Leite, AR; (...); Leite-Moreira, A
Article. 10.1159/000530136. 2023
Clinical and Pathophysiologic Insights of Free triiodothyronine/Free thyroxine Ratio in Patients with Heart Failure with Preserved Ejection Fraction: Data from the NETDiamond Cohort.
Leite, AR; (...); Leite Moreira, A
Article. 2023
Changes in health-related quality of life and treatment effects in chronic heart failure: a meta-analysis
Angelico Goncalves, A; (...); Ferreira, J.
Article. 10.1016/j.ijcard.2023.05.032. 2023
Changes in health-related quality of life and treatment effects in chronic heart failure: a meta-analysis.
Angelico Goncalves, A; (...); Ferreira, JP
Article. 2023
Early combination therapy with SGLT2i and GLP-1 RA or dual GIP/GLP-1 RA in type 2 diabetes
Vale, Catarina; (...); Bergman, Michael
Review. 10.1111/dom.16077. 2024
Early combination therapy with SGLT2i and GLP-1 RA or dual GIP/GLP-1 RA in type 2 diabetes.
Vale, C; (...); Bergman, M
Review. 2024
Editorial: Prediabetes: new insights on the diagnosis, risk stratification, comorbidites, cardiovascular disease, microvascular complications, and treatment
Neves, J., Buysschaert, M, Bergman, M
Article. 10.3389/fendo.2023.1214479. 2023
Effects of Triiodothyronine Treatment in an Animal Model of Heart Failure with Preserved Ejection Fraction
Neves, J.; (...); Leite Moreira, A.
Article. 10.1089/thy.2022.0717. 2023
Effects of Triiodothyronine Treatment in an Animal Model of Heart Failure with Preserved Ejection Fraction.
Neves, JS; (...); Leite Moreira, A
Article. 2023
Efficacy, Toxicity, and Prognostic Factors of Re- treatment With [177Lu]Lu-DOTA-TATE in Patients With Progressing Neuroendocrine Tumors: The Experience of a Single Center
Silva, MM; (...); Duarte, H
Article. 10.7759/cureus.47506. 2023
Efficacy, Toxicity, and Prognostic Factors of Re- treatment With [177Lu]Lu-DOTA-TATE in Patients With Progressing Neuroendocrine Tumors: The Experience of a Single Center.
Silva, MM; (...); Duarte, H
Article. 2023
FIB-4 Index should Guide the Referral of Patients with Metabolic Syndrome to Gastroenterology: The Perspective of a Portuguese Cohort
Borges-Canha, M; (...); Freitas, P
Article. 10.26497/ao230023. 2023
FIB-4 Index should Guide the Referral of Patients with Metabolic Syndrome to Gastroenterology: The Perspective of a Portuguese Cohort.
Borges Canha, M; (...); Freitas, P
Article. 2023
GLP-1 Receptor Agonist Therapy With and Without SGLT2 Inhibitors in Patients With Type 2 Diabetes
Neves, J.; (...); Md, JPF
Article. 10.1016/j.jacc.2023.05.048. 2023
GLP-1 Receptor Agonist Therapy With and Without SGLT2 Inhibitors in Patients With Type 2 Diabetes.
Neves, JS; (...); Md, JPF
Article. 2023
Glucagon-like peptide 1 receptor agonists in heart failure: the need for a rewind
Ferreira, J., Neves, J.
Editorial Material. 10.1002/ejhf.2693. 2022
Glucagon-like peptide 1 receptor agonists in patients with type 2 diabetes with and without chronic heart failure: A meta-analysis of randomized placebo-controlled outcome trials
Ferreira, J.; (...); Neves, J.
Article. 10.1111/dom.14997. 2023
Glucagon-like peptide 1 receptor agonists in patients with type 2 diabetes with and without chronic heart failure: A meta-analysis of randomized placebo-controlled outcome trials.
Ferreira, JP; (...); Neves, JS
Article. 2023
Glucagon-Like Peptide-1 Receptor Agonists Across the Spectrum of Heart Failure
Ferreira, J.; (...); Neves, J.
Review. 10.1210/clinem/dgad398. 2023
Glucagon-Like Peptide-1 Receptor Agonists Across the Spectrum of Heart Failure.
Ferreira, JP; (...); Neves, JS
Review. 2023
Impact of the COVID-19 Pandemic on Maternal Weight Variation and Newborn Anthropometry at Birth.
Metelo Coimbra, C; (...); Neves, JS
Article. 2024
Increased Risk of Heart Failure Hospitalization With GLP-1 Receptor Agonists in Patients With Reduced Ejection Fraction: A Meta-Analysis of the EXSCEL and FIGHT Trials
Neves, J., Packer, M, Ferreira, J.
Article. 10.1016/j.cardfail.2023.03.017. 2023
Increased Risk of Heart Failure Hospitalization With GLP-1 Receptor Agonists in Patients With Reduced Ejection Fraction: A Meta-Analysis of the EXSCEL and FIGHT Trials.
Neves, JS, Packer, M, Ferreira, JP
Article. 2023
Letter regarding the article 'Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial
Ferreira, J., Neves, J.
Letter. 10.1002/ejhf.2694. 2022
Myocardial stretch-induced compliance is abrogated under ischemic conditions and restored by cGMP/PKG-related pathways
Leite Moreira, AM; (...); Louren?o, A.
Article. 10.3389/fphys.2023.1271698. 2023
Myocardial stretch-induced compliance is abrogated under ischemic conditions and restored by cGMP/PKG-related pathways.
Leite Moreira, AM; (...); Lourenço, AP
Article. 2023
Physical exercise and glycemic management in patients with type 1 diabetes on insulin pump therapy-a cross-sectional study.
Ferreira, M; (...); Carvalho, D
Article. 2023
Prediabetes remission after bariatric surgery: a 4-years follow-up study
Canha, M.; (...); Nunes, PML
Article. 10.1186/s12902-024-01537-0. 2024
Prediabetes remission after bariatric surgery: a 4-years follow-up study.
Borges-Canha, M; (...); Nunes, PML
Article. 2024
Relation between weight gain during pregnancy and postpartum reclassification in gestational diabetes
Coelho, S; (...); Ameida, MD
Article. 10.1007/s12020-023-03441-4. 2023
Relation between weight gain during pregnancy and postpartum reclassification in gestational diabetes.
Coelho, S; (...); Ameida, MD
Article. 2023
Response to Letter to Editor From Banerjee et al: "Glucagon-Like Peptide-1 Receptor Agonists Across the Spectrum of Heart Failure"
Ferreira, JP, Neves, JS
Letter. 10.1210/clinem/dgad507. 2023
Risk of adverse events with liraglutide in heart failure with reduced ejection fraction: A post hoc analysis of the FIGHT trial
Neves, J.; (...); Ferreira, J.
Article. 10.1111/dom.14862. 2023
Risk of adverse events with liraglutide in heart failure with reduced ejection fraction: A post hoc analysis of the FIGHT trial.
Neves, JS; (...); Ferreira, JP
Article. 2023
Semaglutide and Cardiovascular Outcomes
Neves, JS, Leite, AR, Ferreira, JP
Letter. 10.1056/NEJMc2400414. 2024
Serum Prolactin Levels and Mortality in Adults Without Prolactinoma: A Meta-Analysis
Papazoglou, Andreas S.; (...); Giannakoulas, George
Article. 10.1210/clinem/dgae087. 2024
Subclinical Thyroid Dysfunction and Cardiovascular Disease.
Lourenco, IM; (...); Neves, JS
Review. 2023
Sulfur Amino Acid Restriction Mitigates High-Fat Diet-Induced Molecular Alterations in Cardiac Remodeling Primarily via FGF21-Independent Mechanisms
Pinheiro, F; (...); Wanders, D
Article. 10.3390/nu16244347. 2024
Sulfur Amino Acid Restriction Mitigates High-Fat Diet-Induced Molecular Alterations in Cardiac Remodeling Primarily via FGF21-Independent Mechanisms.
Pinheiro, F; (...); Wanders, D
Article. 2024
The Impact of Glucagon-Like Peptide-1 Receptor Agonists on Kidney Outcomes A Meta-Analysis of Randomized Placebo-Controlled Trials
Mendonça, L; (...); Ferreira, JP
Article. 10.2215/CJN.0000000584. 2024
The role of Graves' disease in the development of thyroid nodules and thyroid cancer
Soares, MN; (...); Carvalho, D
Article. 10.1530/ETJ-23-0055. 2023
The role of Graves' disease in the development of thyroid nodules and thyroid cancer.
Soares, MN; (...); Carvalho, D
Article. 2023
Time in range and complications of diabetes: a cross-sectional analysis of patients with Type 1 diabetes
Bezerra, MF; (...); Carvalho, D
Article. 10.1186/s13098-023-01219-2. 2023
Time in range and complications of diabetes: a cross-sectional analysis of patients with Type 1 diabetes.
Bezerra, MF; (...); Carvalho, D
Article. 2023
Total thyroidectomy in a patient awaiting heart transplant with amiodarone-induced thyrotoxicosis: A case report
Amador, F; (...); Carvalho, D.
Article. 10.1002/ccr3.6892. 2023
